Director Sales Enablement Strategy Jobs (NOW HIRING)

Magnolia Medical is an early stage, rapid growth commercial-stage medical device company with an opportunity for a Director of Sales Enablement to join this team making a difference every day. Magnolia Medical Technologies is developing solutions to challenges that have long plagued our healthcare system.

Our Steripath® Initial Specimen Diversion Device® for blood collection and contamination prevention has created a new standard of care for prevention of false-positive blood cultures, the gold standard diagnostic test for sepsis. Steripath delivers significant clinical and cost savings benefits which have been extensively proven with large bodies of clinical data and peer-reviewed published studies. Based on this exceptional performance profile, we have an exclusive FDA-cleared indication for reducing blood culture contamination and uniquely provide a money-back Clinical Performance Guarantee for Steripath to our hospital customers.

The Director of Sales Enablement is responsible for improving sales effectiveness through best-in-class onboarding, training, coaching, content development, and field enablement programs. This leader will ensure the sales organization possesses the knowledge, skills, tools, and resources necessary to effectively communicate the company’s value proposition and achieve revenue objectives.

The Director will work closely with Sales Leadership, Sales Operations, Marketing, Customer Success (Clinical), and Product teams to build scalable enablement programs that drive performance, accelerate ramp time, and improve field execution.

This is an ideal role for an experienced Sales training and enablement professional wanting to continue their work with high-performing sales teams driving acute care, multi level hospital medical device sales which require each team member be able to communicate clinical and economic value, including ROI, to diverse stakeholders.

• Develop and execute a comprehensive sales enablement strategy aligned with commercial objectives.
• Partner with Sales Leadership to identify performance gaps and enablement opportunities.
• Create programs that improve sales productivity, effectiveness, and revenue generation.

• Design, implement, and continuously improve onboarding programs for new sales employees.
• Develop and maintain comprehensive training curricula, learning pathways, and certification programs.
• Facilitate instructor‑led, virtual, and field‑based training programs.
• Manage training schedules, logistics, communications, and program execution.

• Develop and maintain sales playbooks, competitive intelligence resources, objection‑handling guides, and customer‑facing tools.
• Ensure field teams have access to current product, clinical, competitive, and market information.
• Translate marketing messaging into practical sales conversations and customer engagement tools.

• Develop quarterly training programs focused on sales skills, product knowledge, clinical education, and competitive positioning.
• Establish continuous learning initiatives to support professional development and commercial excellence.
• Drive adoption of best practices throughout the sales organization.

• Travel with field representatives to assess execution and identify coaching opportunities.
• Provide direct feedback and recommendations to improve customer interactions and sales performance.
• Partner with sales managers to reinforce training and coaching initiatives.

• Utilize CRM and LMS platforms to track training completion, effectiveness, and sales performance metrics.
• Establish KPIs to measure training impact, onboarding effectiveness, and productivity improvements.
• Analyze performance data and adjust programs accordingly.

• Partner with Marketing to ensure consistent messaging and field readiness.
• Collaborate with Product, Clinical Affairs, and Sales Leadership to support product launches and strategic initiatives.
• Serve as the primary enablement liaison across commercial functions.

• Bachelor's degree in Business, Marketing, Communications, Education, or related field.
• 7+ years of progressive experience in sales enablement, sales training, sales leadership, or commercial excellence roles.
• Demonstrated success designing and delivering sales training programs.
• Experience developing onboarding curricula, certification programs, and sales methodologies.
• Healthcare, medical device, diagnostics, biotechnology, or related industry experience strongly preferred.
• Experience working with CRM and LMS platforms.
• Strong facilitation, coaching, presentation, and communication skills.
• Ability to travel approximately 60%.

• CRM systems (e.g., Salesforce, HubSpot).
• Learning Management Systems (LMS).
• Strong analytical and reporting capabilities (Excel, PowerPoint, KPI dashboards).

• Strategic thinker with strong business acumen.
• Exceptional communication and presentation skills.
• Highly organized with strong attention to detail.
• Collaborative leader with the ability to influence cross-functional stakeholders.
• Self‑starter who thrives in a fast‑paced, growth‑oriented environment.
• Strong relationship‑building skills with a positive, team‑focused mindset.

Magnolia Medical Technologies develops, manufactures and markets innovative blood and bodily fluid collection devices to facilitate significant improvements in the accuracy, consistency and predictability of critical laboratory tests.

Dr. Richard Patton, the company’s co‑founder and Medical Director, invented and patented the Initial Specimen Diversion Technique (ISDT™) and Initial Specimen Diversion Device (ISDD®) for blood culture collection and contamination prevention, and authored the seminal peer‑reviewed publication on this technique published in the Journal of Clinical Microbiology in 2010.

The company’s flagship product, Steripath® Initial Specimen Diversion Device® for blood culture collection and contamination prevention, has been clinically proven in 17 clinical studies including 5 peer‑reviewed publications to virtually eliminate the preventable error of blood culture contamination and false positive results for the diagnosis of Sepsis – delivering a reduction in false positives of up to 92% with 12‑month sustained contamination rates as low as 0.2% and an average annualized cost savings of $945,000.

Magnolia is establishing the new standard for blood culture integrity and sepsis testing accuracy with a mission to change national blood culture collection guidelines and contamination benchmarks.

Magnolia has amassed an intellectual property portfolio including more than 70 issued method, apparatus and design patents with more than 50 additional patent applications pending. The total potential market for Magnolia’s technology exceeds $2.0 billion annually.

Magnolia Medical is committed to the continued development and successful marketing of innovative products that will transform the way healthcare is practiced around the world. The company supports this effort by offering competitive compensation, incentive packages, benefits and career growth opportunities to the most qualified candidates in the marketplace. Magnolia Medical Technologies, Inc. is an equal opportunity employer.

For more information, visit magnolia-medical.com